Published in Children (Basel) on April 21, 2015
High Risk Neuroblastoma Study 1.7 of SIOP-Europe (SIOPEN) | NCT01704716
Chronic health conditions in adult survivors of childhood cancer. N Engl J Med (2006) 19.97
Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA (2007) 5.74
Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst (2008) 5.05
Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst (2001) 4.69
A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood (2002) 4.59
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours. Lancet (1991) 4.31
Cancer incidence in persons with Fanconi anemia. Blood (2002) 4.05
Incidence of second primary tumours among childhood cancer survivors. Br J Cancer (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev (2010) 3.24
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood (2009) 2.73
Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry. Haematologica (2008) 2.72
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood (1999) 2.65
High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg (2003) 2.56
Solid cancers after allogeneic hematopoietic cell transplantation. Blood (2008) 2.56
Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat Res (2003) 2.49
Long-term cause-specific mortality among survivors of childhood cancer. JAMA (2010) 2.30
New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol (2003) 2.19
Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer (2009) 2.08
Solid cancers after bone marrow transplantation. J Clin Oncol (2001) 1.99
Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood (2004) 1.97
Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol (1985) 1.95
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. J Natl Cancer Inst (1996) 1.85
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med (1991) 1.83
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol (2005) 1.78
Malignant neoplasms following bone marrow transplantation. Blood (1996) 1.76
Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood (1988) 1.72
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med (1999) 1.59
Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood (2002) 1.57
Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior. J Pediatr Hematol Oncol (2001) 1.54
High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol (2012) 1.53
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer (2012) 1.49
Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood (1988) 1.39
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant (2007) 1.39
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood (2000) 1.37
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients. Am J Transplant (2005) 1.36
The course of five-year survivors of cancer in childhood. J Pediatr (1978) 1.28
The health status of adult survivors of cancer in childhood. Eur J Cancer (1998) 1.26
Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children. Br J Haematol (2001) 1.24
Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood (2013) 1.21
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood (1987) 1.16
Caring for survivors of childhood cancers: the size of the problem. Eur J Cancer (2006) 1.15
Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood (1998) 1.14
High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant (2009) 1.09
Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol (2007) 1.07
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood (1998) 1.06
Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer (2007) 1.01
Donor-derived second hematologic malignancies after cord blood transplantation. Biol Blood Marrow Transplant (2010) 0.98
Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant (2013) 0.97
Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation. Bone Marrow Transplant (2003) 0.97
Secondary solid tumors after allogeneic hematopoietic SCT in Japan. Bone Marrow Transplant (2011) 0.96
Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer (1989) 0.95
Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study. Am J Surg Pathol (2006) 0.95
Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities. Genes Chromosomes Cancer (2006) 0.93
Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol (1998) 0.90
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplant. Leuk Lymphoma (2008) 0.89
High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Bone Marrow Transplant (2010) 0.88
c-MYC is a radiosensitive locus in human breast cells. Oncogene (2014) 0.88
Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer. Cardiol Res Pract (2012) 0.87
EBV-related disease following haematopoietic stem cell transplantation with reduced intensity conditioning. Leuk Lymphoma (2007) 0.86
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study. Bone Marrow Transplant (2014) 0.86
Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer (2007) 0.86
Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation. Transplantation (2013) 0.85
Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantation. Bone Marrow Transplant (2005) 0.85
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours. Pediatr Blood Cancer (2011) 0.85
Nonhematologic malignancies after allogeneic hematopoietic stem cell transplantation: incidence and molecular monitoring. Bone Marrow Transplant (2004) 0.84
Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant (2012) 0.84
Secondary thyroid carcinoma after allogeneic bone marrow transplantation during childhood. Bone Marrow Transplant (2001) 0.84
Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced. Leukemia (2012) 0.83
Second malignant tumors following treatment during childhood and adolescence for cancer. Med Pediatr Oncol (1994) 0.81
Histogenetic phenotypes of B cells in posttransplant lymphoproliferative disorders by immunohistochemical analysis correlate with transplant type: solid organ vs hematopoietic stem cell transplantation. Am J Clin Pathol (2005) 0.81
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma. Pediatr Blood Cancer (2014) 0.79
Treatment of solid tumors following allogeneic bone marrow transplantation. Bone Marrow Transplant (2000) 0.78
Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution. Int J Hematol (2011) 0.78
Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004. Leuk Lymphoma (2011) 0.78